Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
1
Page:
233-252
Author(s):
Joanna Bandorowicz-Pikula
Proteomic Approaches Contributing to the Understanding of Neurodegenerative Diseases: Focus on Alzheimers Disease
Journal:
Current Proteomics
Volume:
1
Page:
221-229
Author(s):
Ephrem Engidawork and Gert Lubec
Cytochrome P450 in Neurological Disease
Journal:
Current Drug Metabolism
Volume:
5
Page:
225-234
Author(s):
M. Liu, P. D. Hurn and N. J. Alkayed
Rapid Screening of Antioxidants in Pharmaceutical Formulation Development Using Cyclic Voltammetry - Potential And Limitations
Journal:
Current Drug Discovery Technologies
Volume:
1
Page:
173-179
Author(s):
Tiehua Huang, Ping Gao and Michael J. Hageman
Antipsychotic Drugs: Evolving Mechanisms of Action with Improved Therapeutic Benefits
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
217-226
Author(s):
B. Dean and E. Scarr
Programmed Axon Death, Synaptic Dysfunction and the Ubiquitin Proteasome System
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
3
Page:
227-238
Author(s):
M. P. Coleman and R. R. Ribchester
Anti-HIV Drug Distribution to the Central Nervous System
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1313-1324
Author(s):
S. A. Thomas
Are the Extracelluar Pathways a Conduit for the Delivery of Therapeutics to the Brain?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1365-1370
Author(s):
William A. Banks
Molecular Mechanisms, Proteinopathies and Therapeutic Strategies in Neurodegenerative Disorders
Journal:
Current Genomics
Volume:
5
Page:
327-346
Author(s):
L. K. Sengupta and S. Sengupta
Brain Oxidative Markers in Stress: Possible New Drug Targets Against Neuroinflammation
Journal:
Current Neuropharmacology
Volume:
2
Page:
183-189
Author(s):
Jose L.M. Madrigal, Javier Caso, Olivia Hurtado, Ignacio Lizasoain, Maria A. Moro, Pedro Lorenzo and Juan C. Leza